Supported by and working closely with the PDA Quality and Regulatory Affairs Department is the PDA Regulatory Affairs and Quality Committee (RAQC). The RAQC is a critical source for identifying global regulatory issues of interest to PDA members globally.

Once a regulatory issue is identified, the RAQC forms a Task Force to study and prepare written comments. The list of recommendations they prepare, PDA Regulatory Comments, is then submitted back to the originating agency/organization (i.e., FDA, EMEA, WHO, etc.) for review/inclusion and consideration for inclusion into a the final guidance regulatory document. PDA Regulatory Comments are also posted to the PDA Web site for public viewing and are highlighted monthly in the PDA Letter.